Accéder au contenu
Merck

Requirement of ryanodine receptors for pacemaker Ca2+ activity in ICC and HEK293 cells.

Journal of cell science (2004-06-01)
Masahiro Aoyama, Aki Yamada, Jing Wang, Susumu Ohya, Shinji Furuzono, Takayo Goto, Shingo Hotta, Yasushi Ito, Tatsuaki Matsubara, Kaoru Shimokata, S R Wayne Chen, Yuji Imaizumi, Shinsuke Nakayama
RÉSUMÉ

Intracellular Ca(2+) ([Ca(2+)](i)) oscillations seen in interstitial cells of Cajal (ICCs) are considered to be the primary pacemaker activity in the gut. Here, we show evidence that periodic Ca(2+) release from intracellular Ca(2+) stores produces [Ca(2+)](i) oscillations in ICCs, using cell cluster preparations isolated from mouse ileum. The pacemaker [Ca(2+)](i) oscillations in ICCs are preserved in the presence of dihydropyridine Ca(2+) antagonists, which suppress Ca(2+) activity in smooth muscle cells. However, applications of drugs affecting either ryanodine receptors or inositol 1,4,5-trisphosphate receptors terminated [Ca(2+)](i) oscillations at relatively low concentrations. RT-PCR analyses revealed a predominant expression of type 3 RyR (RyR3) in isolated c-Kit-immunopositive cells (ICCs). Furthermore, we demonstrate that pacemaker-like global [Ca(2+)](i) oscillation activity is endowed by introducing RyR3 into HEK293 cells, which originally express only IP(3)Rs. The reconstituted [Ca(2+)](i) oscillations in HEK293 cells possess essentially the same pharmacological characteristics as seen in ICCs. The results support the functional role of RyR3 in ICCs.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Monoclonal Anti-Ryanodine Receptor antibody produced in mouse, clone 34C, ascites fluid